✦ LIBER ✦

Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer

✍ Scribed by Justin C. Chura; Kelin Van Iseghem; Levi S. Downs Jr.; Linda F. Carson; Patricia L. Judson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab combination therapy in heavi

✍ Jason D. Wright; Dana Viviano; Matthew A. Powell; Randall K. Gibb; David G. Mutc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Second complete remission induced by cyc

✍ Alfonso Sánchez-Muñoz; José Miguel Jurado; Elisabeth Pérez-Ruiz; Emilio Alba 📂 Article 📅 2009 🏛 Springer Milan 🌐 Spanish ⚖ 118 KB

Weekly topotecan in heavily pretreated p

✍ David M. O'Malley; Masoud Azodi; Anita Makkenchery; Jacob Tangir; Jessica McAlpi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Combined oral cyclophosphamide and bevac

✍ José Miguel Jurado García; Alfonso Sánchez; Bella Pajares; Elisabeth Pérez; Lore 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 189 KB

Combined oral cyclophosphamide and bevac

✍ José Miguel Jurado; Alfonso Sánchez; Bella Pajares; Elisabeth Pérez; Lorenzo Alo 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 84 KB

Feasibility study of oral cyclophosphami

✍ Yoh Watanabe; Tomomaro Etoh; Eiji Koike; Yoshiaki Mizuno; Wei-Min Wang; Hiroshi 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 141 KB